Centre for Research and Science, Faculty of Health Sciences, Palacký University Olomouc, Olomouc, Czech Republic.
Centre for Research and Science, Faculty of Health Sciences, Palacký University Olomouc, Olomouc, Czech Republic.
J Pain Symptom Manage. 2018 Feb;55(2):444-450. doi: 10.1016/j.jpainsymman.2017.10.008. Epub 2017 Nov 9.
The Patient Dignity Inventory (PDI) is a valid, reliable screening tool to assess a range of issues that have been reported to affect the sense of dignity in patients with life-limiting conditions.
We investigated the item characteristics, factor structure, and reliability of the Czech version of the PDI (PDI-CZ) among cancer and noncancer patients.
The PDI was translated into the Czech language following state-of-the-art criteria (a five-stage proceeding method for the translation). Two hundred thirty-nine participants completed the study (136 cancer and 103 noncancer patients). Internal consistency, test-retest reliability, and factor analysis were used for validation of the PDI-CZ.
A Czech version of the PDI was obtained. The Cronbach's α for PDI-CZ was 0.92. Item 22 (not feeling supported by my health care providers) did not correlate with any other items, and it was skipped for factor analysis processing for this reason. Factor analysis resulted in a four-factor solution, accounting for 56.34% of the overall variance (factor loadings range, 0.37-0.92). The factor labels were as follows: loss of purpose of life; loss of autonomy; loss of confidence; and loss of social support (internal consistencies range, Cronbach's α 0.58-0.90). Test-retest reliability was assessed with 25 patients after two weeks. The resulting range of the Gwet's coefficient, AC1, was between 0.58 and 1.00.
The results from the study support the reliability of the PDI-CZ and its future use in patients with incurable cancer and noncancer patients.
患者尊严量表(PDI)是一种有效的、可靠的筛选工具,用于评估一系列已被报道的影响生命终末期患者尊严感的问题。
我们研究了癌症和非癌症患者中 PDICZ 的项目特征、因子结构和信度。
PDI 按照最先进的标准(五阶段翻译程序)被翻译成捷克语。239 名参与者完成了这项研究(136 名癌症患者和 103 名非癌症患者)。使用内部一致性、重测信度和因子分析来验证 PDICZ。
获得了 PDICZ 的捷克语版本。PDICZ 的 Cronbach's α 为 0.92。项目 22(没有感受到我的医疗保健提供者的支持)与任何其他项目都没有相关性,因此出于这个原因,它被跳过进行因子分析处理。因子分析产生了一个四因子解决方案,占总方差的 56.34%(因子负荷范围,0.37-0.92)。因子标签如下:生命目的丧失;自主权丧失;信心丧失;社会支持丧失(内部一致性范围,Cronbach's α 0.58-0.90)。25 名患者在两周后进行了重测信度评估。Gwet 的系数 AC1 的范围为 0.58 到 1.00。
研究结果支持 PDICZ 的可靠性及其在不可治愈的癌症和非癌症患者中的未来应用。